To meet the changing needs of the industry, MVP is also involved in an extensive research and development program of the products through the signing of a Memorandum of Understanding with Universiti Putra Malaysia. All vaccines produced by MVP are thoroughly researched and tested as to ensure a high degree of efficacy.

The R&D division of MVP mainly concentrates on the commercialisation of R&D from local research institutions, universities and acquisition of technology developed by foreign parties, which has relevance to the company’s production and marketing strategy.